● Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Condition: T-cell Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma · Sponsor: Wugen, Inc.

PhasePhase 2

Planned participants125

Who can joinAll sexes, 1 Year to no upper limit

Healthy volunteersNo

About this study

The T-RRex study evaluates the efficacy of WU-CART-007 for patients with Relapsed/Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL)/Lymphoblastic Lymphoma (LBL) and to WU-CART-007 as a therapy to induce complete Minimum Residual Disease (MRD) negative response

This description comes directly from the study's public registry record.

Talk to the study team

Wugen Clinical Trials · 314-501-1968 · clinicaltrials@wugen.com

Always discuss trial participation with your own doctor first.

Locations (15)

City of Hope	Duarte, California, United States	Recruiting
Children's Hospital Los Angeles	Los Angeles, California, United States	Recruiting
Colorado Blood Cancer Institute	Denver, Colorado, United States	Recruiting
H. Lee Moffitt Cancer Center and Research Institute Hospital	Tampa, Florida, United States	Recruiting
Washington University Saint Louis	St Louis, Missouri, United States	Recruiting
Oncology Hematology Care	Cincinnati, Ohio, United States	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati, Ohio, United States	Recruiting
Children's Hospital of Philadelphia	Philadelphia, Pennsylvania, United States	Recruiting
TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy	Nashville, Tennessee, United States	Recruiting
MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Sarah Cannon Transplant and Cellular Therapy Methodist Hospital	San Antonio, Texas, United States	Recruiting
Sarah Cannon, Virginia Oncology Associates	Norfolk, Virginia, United States	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06514794